SC 13G/A 1 tm2215706d1_sc13ga.htm SC 13G/A

	UNITED STATES
	SECURITIES AND EXCHANGE COMMISSION
	Washington, D.C. 20549

SCHEDULE 13G

(Rule 13d-102)

Information Statement Pursuant to Rules 13d-1

Under the Securities Exchange Act of 1934
(Amendment No. 9)*

SURMODICS, INC.

(Name of Issuer)

Common Stock, Par Value of $0.05 Per Share

(Title of Class of Securities)

868873100

(CUSIP Number)

May 10, 2022

Date of Event Which Requires Filing of the Statement

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

x	Rule 13d-1(b)
o	Rule 13d-1(c)
¨	Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 868873100

Schedule 13G

Page 2 of 13

	1.	Name of Reporting Person S.S. or I.R.S. Identification No. of Above Person Trigran Investments, Inc.

	2.	Check the Appropriate Box if a Member of a Group
		(a)		o
		(b)		x

	3.	SEC Use Only

	4.	Citizenship or Place of Organization Illinois corporation

Number of Shares Beneficially Owned by Each Reporting Person With			5.		Sole Voting Power 0

			6.		Shared Voting Power 2,043,459 shares of common stock

			7.		Sole Dispositive Power 0

			8.		Shared Dispositive Power 2,179,453 shares of common stock

	9.	Aggregate Amount Beneficially Owned by Each Reporting Person 2,179,453 shares of common stock (1)

	10.	Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares o

	11.	Percent of Class Represented by Amount in Row (9) Approximately 15.6% (based on 13,990,000 shares of common stock issued and outstanding as of April 22, 2022 pursuant to the Surmodics, Inc. Form 10-Q filed with the SEC on April 27, 2022)

	12.	Type of Reporting Person IA/CO

(1) The Reporting Person disclaims beneficial ownership of the shares reported in this Schedule 13G, except to the extent of its pecuniary interest.

CUSIP No. 868873100

Schedule 13G

Page 3 of 13

	1.	Name of Reporting Person S.S. or I.R.S. Identification No. of Above Person Douglas Granat

	2.	Check the Appropriate Box if a Member of a Group
		(a)		o
		(b)		x

	3.	SEC Use Only

	4.	Citizenship or Place of Organization U.S. Citizen

Number of Shares Beneficially Owned by Each Reporting Person With			5.		Sole Voting Power 0

			6.		Shared Voting Power 2,043,459 shares of common stock

			7.		Sole Dispositive Power 0

			8.		Shared Dispositive Power 2,179,453 shares of common stock

	9.	Aggregate Amount Beneficially Owned by Each Reporting Person 2,179,453 shares of common stock (1)

	10.	Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares o

	11.	Percent of Class Represented by Amount in Row (9) Approximately 15.6% (based on 13,990,000 shares of common stock issued and outstanding as of April 22, 2022 pursuant to the Surmodics, Inc. Form 10-Q filed with the SEC on April 27, 2022)

	12.	Type of Reporting Person IN/HC

(1) The Reporting Person disclaims beneficial ownership of the shares reported in this Schedule 13G, except to the extent of his pecuniary interest.

CUSIP No. 868873100

Schedule 13G

Page 4 of 13

	1.	Name of Reporting Person S.S. or I.R.S. Identification No. of Above Person Lawrence A. Oberman

	2.	Check the Appropriate Box if a Member of a Group
		(a)		o
		(b)		x

	3.	SEC Use Only

	4.	Citizenship or Place of Organization U.S. Citizen

Number of Shares Beneficially Owned by Each Reporting Person With			5.		Sole Voting Power 0

			6.		Shared Voting Power 2,043,459 shares of common stock

			7.		Sole Dispositive Power 0

			8.		Shared Dispositive Power 2,179,453 shares of common stock

	9.	Aggregate Amount Beneficially Owned by Each Reporting Person 2,179,453 shares of common stock (1)

	10.	Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares o

	11.	Percent of Class Represented by Amount in Row (9) Approximately 15.6% (based on 13,990,000 shares of common stock issued and outstanding as of April 22, 2022 pursuant to the Surmodics, Inc. Form 10-Q filed with the SEC on April 27, 2022)

	12.	Type of Reporting Person IN/HC

(1) The Reporting Person disclaims beneficial ownership of the shares reported in this Schedule 13G, except to the extent of his pecuniary interest.

CUSIP No. 868873100

Schedule 13G

Page 5 of 13

	1.	Name of Reporting Person S.S. or I.R.S. Identification No. of Above Person Steven G. Simon

	2.	Check the Appropriate Box if a Member of a Group
		(a)		o
		(b)		x

	3.	SEC Use Only

	4.	Citizenship or Place of Organization U.S. Citizen

Number of Shares Beneficially Owned by Each Reporting Person With			5.		Sole Voting Power 0

			6.		Shared Voting Power 2,043,459 shares of common stock

			7.		Sole Dispositive Power 0

			8.		Shared Dispositive Power 2,179,453 shares of common stock

	9.	Aggregate Amount Beneficially Owned by Each Reporting Person 2,179,453 shares of common stock (1)

	10.	Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares o

	11.	Percent of Class Represented by Amount in Row (9) Approximately 15.6% (based on 13,990,000 shares of common stock issued and outstanding as of April 22, 2022 pursuant to the Surmodics, Inc. Form 10-Q filed with the SEC on April 27, 2022)

	12.	Type of Reporting Person IN/HC

(1) The Reporting Person disclaims beneficial ownership of the shares reported in this Schedule 13G, except to the extent of his pecuniary interest.

CUSIP No. 868873100

Schedule 13G

Page 6 of 13

	1.	Name of Reporting Person S.S. or I.R.S. Identification No. of Above Person Bradley F. Simon

	2.	Check the Appropriate Box if a Member of a Group
		(a)		o
		(b)		x

	3.	SEC Use Only

	4.	Citizenship or Place of Organization U.S. Citizen

Number of Shares Beneficially Owned by Each Reporting Person With			5.		Sole Voting Power 0

			6.		Shared Voting Power 2,043,459 shares of common stock

			7.		Sole Dispositive Power 0

			8.		Shared Dispositive Power 2,179,453 shares of common stock

	9.	Aggregate Amount Beneficially Owned by Each Reporting Person 2,179,453 shares of common stock (1)

	10.	Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares o

	11.	Percent of Class Represented by Amount in Row (9) Approximately 15.6% (based on 13,990,000 shares of common stock issued and outstanding as of April 22, 2022 pursuant to the Surmodics, Inc. Form 10-Q filed with the SEC on April 27, 2022)

	12.	Type of Reporting Person IN/HC

(1) The Reporting Person disclaims beneficial ownership of the shares reported in this Schedule 13G, except to the extent of his pecuniary interest.

CUSIP No. 868873100

Schedule 13G

Page 7 of 13

	1.	Name of Reporting Person S.S. or I.R.S. Identification No. of Above Person Steven R. Monieson

	2.	Check the Appropriate Box if a Member of a Group
		(a)		o
		(b)		x

	3.	SEC Use Only

	4.	Citizenship or Place of Organization U.S. Citizen

Number of Shares Beneficially Owned by Each Reporting Person With			5.		Sole Voting Power 0

			6.		Shared Voting Power 2,043,459 shares of common stock

			7.		Sole Dispositive Power 0

			8.		Shared Dispositive Power 2,179,453 shares of common stock

	9.	Aggregate Amount Beneficially Owned by Each Reporting Person 2,179,453 shares of common stock (1)

	10.	Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares o

	11.	Percent of Class Represented by Amount in Row (9) Approximately 15.6% (based on 13,990,000 shares of common stock issued and outstanding as of April 22, 2022 pursuant to the Surmodics, Inc. Form 10-Q filed with the SEC on April 27, 2022)

	12.	Type of Reporting Person IN/HC

(1) The Reporting Person disclaims beneficial ownership of the shares reported in this Schedule 13G, except to the extent of his pecuniary interest.

CUSIP No. 868873100

Schedule 13G

Page 8 of 13

Item 1(a)	Name of Issuer: Surmodics, Inc.
Item 1(b)	Address of Issuer’s Principal Executive Offices: 9924 West 74^th Street Eden Prairie, Minnesota 55344

Item 2(a)	Name of Person Filing See Item 2(c)
Item 2(b)	Address of Principal Business Office See Item 2(c)
Item 2(c)	Citizenship Trigran Investments, Inc. 630 Dundee Road, Suite 230 Northbrook, IL 60062 Illinois corporation Douglas Granat 630 Dundee Road, Suite 230 Northbrook, IL 60062 U.S. Citizen Lawrence A. Oberman 630 Dundee Road, Suite 230 Northbrook, IL 60062 U.S. Citizen Steven G. Simon 630 Dundee Road, Suite 230 Northbrook, IL 60062 U.S. Citizen Bradley F. Simon 630 Dundee Road, Suite 230 Northbrook, Illinois 60062 U.S. Citizen Steven R. Monieson 630 Dundee Road, Suite 230 Northbrook, Illinois 60062 U.S. Citizen
Item 2(d)	Title of Class of Securities: Common Stock, par value of $0.05 per share
Item 2(e)	CUSIP Number: 868873100

CUSIP No. 868873100

Schedule 13G

Page 9 of 13

Item 3	If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

	(a)	o	Broker or dealer registered under section 15 of the Exchange Act;
	(b)	o	Bank as defined in section 3(a)(6) of the Exchange Act;
	(c)	o	Insurance company as defined in section 3(a)(19) of the Exchange Act;
	(d)	o	Investment company registered under section 8 of the Investment Company Act;
	(e)	x	An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
	(f)	o	An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
	(g)	x	A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
	(h)	o	A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;
	(i)	o	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act;
	(j)	o	A non-U.S. institution in accordance with Rule 13d–1(b)(1)(ii)(J);
	(k)	o	Group, in accordance with Rule 13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 13d–1(b)(1)(ii)(J), please specify the type of institution:
If this statement is filed pursuant to Rule 13d-1(c), check this box. o

Item 4	Ownership:(2)
	(a)	Amount beneficially owned: Incorporated by reference to Item 9 of the cover page pertaining to each reporting person.
	(b)	Percent of class: Incorporated by reference to Item 11 of the cover page pertaining to each reporting person.
	(c)	Number of shares as to which such person has:

		(i)	Sole power to vote or to direct the vote: Incorporated by reference to Item 5 of the cover page pertaining to each reporting person.
		(ii)	Shared power to vote or to direct the vote: Incorporated by reference to Item 6 of the cover page pertaining to each reporting person.
		(iii)	Sole power to dispose or to direct the disposition of: Incorporated by reference to Item 7 of the cover page pertaining to each reporting person.
		(iv)	Shared power to dispose or to direct the disposition of: Incorporated by reference to Item 8 of the cover page pertaining to each reporting person.
(2) Douglas Granat, Lawrence A. Oberman, Steven G. Simon, Bradley F. Simon, and Steven R. Monieson are the controlling shareholders and officers of Trigran Investments, Inc. and thus may be considered the beneficial owners of shares beneficially owned by Trigran Investments, Inc.

CUSIP No. 868873100

Schedule 13G

Page 10 of 13

Item 5	Ownership of Five Percent or Less of a Class:
	Not Applicable.


Item 6	Ownership of More than Five Percent on Behalf of Another Person:
Owners of accounts managed by Trigran Investments, Inc. have or may have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, securities held in their accounts. Except as set forth immediately below, no such account has such power with respect to more than five percent of the class of securities to which this Schedule 13G relates. Trigran Investments, Inc. provides investment advisory services to Trigran Investments, L.P., a private investment partnership for which Trigran Investments, Inc. has sole investment discretion and voting authority. Trigran Investments, L.P. beneficially owns more than five percent of the class of securities to which this Schedule 13G relates and has separately filed a Schedule 13G contemporaneously herewith. The shares beneficially owned by Trigran Investments, L.P. are included in the total number of shares referenced in this Schedule 13G.
Item 7	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company:
	Not Applicable.

Item 8	Identification and Classification of Members of the Group:
	Not Applicable.

Item 9	Notice of Dissolution of Group:
	Not Applicable.

Item 10	Certification:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

CUSIP No. 868873100

Schedule 13G

Page 11 of 13

After reasonable inquiry and to the best of its knowledge and belief, the undersigned Reporting Persons certify that the information set forth in this statement is true, complete, and correct.

Date: May 16, 2022

TRIGRAN INVESTMENTS, INC.

By:	/s/ Lawrence A. Oberman
Name:	Lawrence A. Oberman
Title:	Executive Vice President

/s/ Douglas Granat
Douglas Granat

/s/ Lawrence A. Oberman
Lawrence A. Oberman

/s/ Steven G. Simon
Steven G. Simon

/s/ Bradley F. Simon
Bradley F. Simon

/s/ Steven R. Monieson
Steven R. Monieson

CUSIP No. 868873100

Schedule 13G

Page 12 of 13

INDEX TO EXHIBITS

	PAGE

EXHIBIT 1: Agreement to Make a Joint Filing	1

CUSIP No. 868873100

Schedule 13G

Page 13 of 13

Exhibit 1

EXHIBIT 1 TO SCHEDULE 13G

May 16, 2022

In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, TRIGRAN INVESTMENTS, INC., DOUGLAS GRANAT, LAWRENCE A. OBERMAN, STEVEN G. SIMON, BRADLEY F. SIMON and STEVEN R. MONIESON each hereby agree to the joint filing of this statement on Schedule 13G (including any and all amendments hereto). In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement on Schedule 13G. A copy of this Agreement shall be attached as an exhibit to the Statement on Schedule 13G filed on behalf of each of the parties hereto, to which this Agreement relates.

This Agreement may be executed in multiple counterparts, each of which shall constitute an original, one and the same instrument.

TRIGRAN INVESTMENTS, INC.

By:	/s/ Lawrence A. Oberman
Name:	Lawrence A. Oberman
Title:	Executive Vice President

/s/ Douglas Granat
Douglas Granat

/s/ Lawrence A. Oberman
Lawrence A. Oberman

/s/ Steven G. Simon
Steven G. Simon

/s/ Bradley F. Simon
Bradley F. Simon

/s/ Steven R. Monieson
Steven R. Monieson

SEC Form SC 13G/A filed by Surmodics Inc. (Amendment)